120 related articles for article (PubMed ID: 36203318)
21. miR-4735-3p inhibits cell migration and invasion of gastric cancer by downregulating NEDD9.
Ma Y
Oncol Lett; 2022 Aug; 24(2):253. PubMed ID: 35765282
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.
Dai J; Van Wie PG; Fai LY; Kim D; Wang L; Poyil P; Luo J; Zhang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():106-112. PubMed ID: 27664007
[TBL] [Abstract][Full Text] [Related]
23. The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility.
Ahn J; Sanz-Moreno V; Marshall CJ
J Cell Sci; 2012 Apr; 125(Pt 7):1814-26. PubMed ID: 22328516
[TBL] [Abstract][Full Text] [Related]
24. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
25. Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer.
Guo Q; Qin W; Li B; Yang H; Guan J; Liu Z; Li S
Pathol Res Pract; 2014 Dec; 210(12):793-8. PubMed ID: 25445115
[TBL] [Abstract][Full Text] [Related]
26. High expression of NEDD9 predicts adverse outcomes of colorectal cancer patients.
Li P; Zhou H; Zhu X; Ma G; Liu C; Lin B; Mao W
Int J Clin Exp Pathol; 2014; 7(5):2565-70. PubMed ID: 24966970
[TBL] [Abstract][Full Text] [Related]
27. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
[TBL] [Abstract][Full Text] [Related]
28. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
[TBL] [Abstract][Full Text] [Related]
29. E-cadherin in gastric carcinomas: Relations with histological parameters and its prognostic value.
Schizas D; Moris D; Michalinos A; Kanavidis P; Oikonomou D; Papalampros A; Machairas A; Liakakos T
J BUON; 2017; 22(2):383-389. PubMed ID: 28534359
[TBL] [Abstract][Full Text] [Related]
30. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
[TBL] [Abstract][Full Text] [Related]
31. NEDD9 expression is correlated with epithelial-to-mesenchymal transition markers in colorectal cancer.
Xue YZ; Wu TL; Dai YY; Sheng YY; Wu YM; Xia BL; Huang ZW
Int J Clin Exp Pathol; 2017; 10(8):8640-8646. PubMed ID: 31966721
[TBL] [Abstract][Full Text] [Related]
32. NEDD9 promotes invasion and migration of colorectal cancer cell line HCT116 via JNK/EMT.
Meng H; Wu J; Huang Q; Yang X; Yang K; Qiu Y; Ren J; Shen R; Qi H
Oncol Lett; 2019 Oct; 18(4):4022-4029. PubMed ID: 31516604
[TBL] [Abstract][Full Text] [Related]
33. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
Zuo X; Cai J; Chen Z; Li Y; Zhang D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition.
Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H
Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484
[TBL] [Abstract][Full Text] [Related]
35. NEDD9 stabilizes focal adhesions, increases binding to the extra-cellular matrix and differentially effects 2D versus 3D cell migration.
Zhong J; Baquiran JB; Bonakdar N; Lees J; Ching YW; Pugacheva E; Fabry B; O'Neill GM
PLoS One; 2012; 7(4):e35058. PubMed ID: 22509381
[TBL] [Abstract][Full Text] [Related]
36. Expression of e-cadherin and catenins in early gastric cancer.
Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
[TBL] [Abstract][Full Text] [Related]
37. [Knockdown of NEDD9 inhibits the proliferation, invasion and migration of esophageal carcinoma EC109 cells].
Zhang W; Li S; Zhao Y; Guo N; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1662-1666. PubMed ID: 27916098
[TBL] [Abstract][Full Text] [Related]
38. Isorhapontigenin (ISO) inhibits malignant cell transformation, migration, and invasion through MEG3/NEDD9 signaling in Cr(VI)-transformed cells.
Shi S; Li J; Zhang Z; Tu H; Max C
Toxicol Appl Pharmacol; 2023 Oct; 476():116661. PubMed ID: 37619952
[TBL] [Abstract][Full Text] [Related]
39. Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process.
Zhang K; Yang G; Wu W; Zhang J; Xia X; Jiang T; Cao J; Huang K; Qiu Z; Huang C
Recent Pat Anticancer Drug Discov; 2016; 11(2):236-44. PubMed ID: 26817615
[TBL] [Abstract][Full Text] [Related]
40. Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.
Li D; Zhang J; Xi Y; Zhang L; Li W; Cui J; Xing R; Pan Y; Pan Z; Li F; Lu Y
BMC Cancer; 2015 Sep; 15():637. PubMed ID: 26373288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
